South Shore Capital Advisors’s Elevance Health ELV Stock Holding History

South Shore Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$326K	Buy	+843	New	+$313K	0.22%	103

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

South Shore Capital Advisors's ELV Position: Q2 2026 in Review

South Shore Capital Advisors opened a new position in Elevance Health (ELV) in Q2 2026: 843 shares worth $326K. The stake represents 0.22% of the portfolio and ranks #103 among its holdings.

1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

South Shore Capital Advisors held 843 shares of Elevance Health worth $326K as of Q2 2026.
Elevance Health was a new South Shore Capital Advisors position in Q2 2026.
Elevance Health made up 0.22% of South Shore Capital Advisors's portfolio in Q2 2026, its #103 holding.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on South Shore Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.